The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Towards Better Management Of Obstructive Sleep Apnoea In Chronic Tetraplegia
Funder
National Health and Medical Research Council
Funding Amount
$71,636.00
Summary
Approximately 50% of people with tetraplegia have obstructive sleep apnoea (OSA); a condition where their throat closes during sleep. OSA is known to make living with tetraplegia much more difficult. This project aims to develop a way to screen for OSA in tetraplegia without a full sleep study (an expensive and often inaccessible test) and to understand the issues faced by clinicians in managing OSA in this group of patients so that strategies can be designed to improve diagnosis and treatment.
The Impact Of Circadian Disturbances On Sleep Quality, Cognition And Psychiatric Symptoms In Neurodegenerative Disease
Funder
National Health and Medical Research Council
Funding Amount
$496,340.00
Summary
There is an increasing awareness that neurodegenerative diseases are associated with disturbances in sleep. Our group have recognised that patterns of sleep disturbance in these patients are also related to problems with memory and mood. The proposed study will be the first of its kind to explore whether disruptions in the circadian system represent a common mechanism underlying these comorbid disease features. Understanding this pathology will hopefully lead to the development of new therapies.